Journal of Obesity & Metabolic Syndrome, 30 (1), 2031
Current management of hyperkalemia in non-dialysis CKD: Longitudinal study of patients receiving stable nephrology care
The Bottom Line In under two decades, GLP-1 agonists moved from niche diabetes drugs to pillars of cardiometabolic carelowering glucose, reducing weight, and, as SELECT showed, preventing heart attacks
Made with a carefully selected, vegetarian formula free from gluten, dairy, soy, peanuts, fish, shellfish, sesame, egg, and artificial dyes or preservatives-so it fits seamlessly into a variety of lifestyles
Most adults who have taken GLP-1 drugs say they took them to treat a chronic condition including diabetes or heart disease (62%), while about four in ten say they took them primarily to lose weight, the KFF survey found
Weekly injections deliver higher absorption rates and consistent dosing, which translates to stronger appetite suppression and more predictable weight loss progress
